Catalyst Wire Dossier Catalyst Wire Dossier

0.3% Sodium Hyaluronate Eye Drop

sodium hyaluronate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 0.3% Sodium Hyaluronate Eye Drop, covering 2016-12-22 to 2016-12-22. Get the full timeline:

Most recent: Clinical Trial Update: 0.3% Sodium Hyaluronate Eye Drop to Prevent Recurrent Corneal Epithelium Exfoliation [Phase 3]

See pricing